Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2014 pubmed 25 citations

Postacute effects of kisspeptin-10 on neuronal injury induced by L-methionine in rats.

Akkaya. Hatice H; Kilic. Ertugrul E; Dinc. Signem Eyuboglu SE; Yilmaz. Bayram B

Key Findings

  • Methionine overload caused increased neuronal apoptosis and oxidative stress (higher MDA, lower glutathione, loss of SOD activity).
  • Kisspeptin-10 alone had no harmful effect on brain cells.
  • When given after methionine injury, kisspeptin-10 reduced cell death, lowered MDA levels, raised glutathione, and fully restored SOD activity.

Practical Outcomes

  • The study suggests kisspeptin-10 may have neuroprotective antioxidant properties, but it’s an early‑stage animal experiment. There’s no human dosage or safety data, so it isn’t ready for self‑experimentation or supplementation. Enthusiasts should view it as a mechanistic hint that warrants further research before any real‑world protocol can be designed.

Summary

In rats, a single dose of kisspeptin-10 given after a brain injury caused by excess methionine helped protect brain cells. It lowered markers of oxidative damage, boosted the brain's natural antioxidant glutathione, and restored the activity of an important antioxidant enzyme (SOD). The peptide itself didn’t cause any extra cell death.

Abstract

Apart from its effect on the regulation of reproductive function, recent studies indicate that kisspeptin may play roles in the antioxidant defense system. The antioxidant defense system and oxidative stress contribute to the etiology and pathogenesis of neuronal cell death after brain injury. We have investigated the postacute effect of kisspeptin-10 on brain injury induced by L-methionine. DNA fragmentation, malondialdehyde (MDA), reduced glutathione levels, and superoxide dismutase (SOD) activities were analyzed. Our results showed that methionine treatment increases apoptotic cell death. Kisspeptin alone showed no side effect on apoptotic cell death. However, kisspeptin treatment reversed the proapoptotic effect of methionine associated with reduced MDA and increased glutathione levels. Furthermore, SOD activity was completely depleted in methionine-treated animals. In conclusion, our results revealed that delayed kisspeptin-10 treatment reduces neuronal cell death by activation of SOD activity.

Study Information

Provider

pubmed

Year

2014

Date

2014-05-23T00:00:00.000Z

DOI

10.1002/jbt.21573

Citations

25

References

40